Henry Schein Releases 2022 Sustainability and Corporate Social Responsibility Report, Demonstrating Company’s Commitment to ‘Delivering Solutions for a Healthier Tomorrow’

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the publication of its 2022 Sustainability and Corporate Social Responsibility (CSR) Report, titled “Delivering Solutions for a Healthier Tomorrow.”

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230724078080/en/

Henry Schein: Delivering Solutions for a Healthier Tomorrow

As part of the Company’s work to enhance its disclosures, Henry Schein reported on its sustainability efforts in 2022 in accordance with Sustainability Accounting Standards Board and Global Reporting Initiative Standards. The CSR Report highlights Henry Schein's efforts to promote responsible business practices and make a positive impact on society.

“Throughout Henry Schein’s more than 90 year history, we have remained committed to our five constituents: customers, supplier partners, investors, Team Schein Members, and society at large,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, Inc.

“Guided by our purpose-driven mission and higher ambition model, we continue to operate as a socially responsible and sustainable organization dedicated to ‘Delivering Solutions for a Healthier Tomorrow.’ This year’s Report reflects these commitments, and we look forward to continuing to build on this activity in the years to come.”

To learn more about Henry Schein’s corporate citizenship efforts and to view the full 2022 Sustainability and CSR Report, along with our Reporting Index and second Task Force on Climate-related Financial Disclosures report, please visit www.henryschein.com/corporatecitizenship

About Henry Schein, Inc. Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.
Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively.

These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.6 billion in 2022, and have grown at a compound annual rate of approximately 12.1 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein Australia at www.henryschein.com.au, facebook.com/henryscheinhalas, instagram.com/henryscheinaus, and linkedin.com/company/henry-schein-australia.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230724078080/en/
Contact: Ann Marie Gothard, Vice President, Corporate Media Relations, annmarie.gothard@henryschein.com, (631) 390 – 8169 Source: Henry Schein, Inc.

Latest Blog Articles

Clinical Case Study: A Next-Generation Endodontic Material

CLINICAL CASE I By Gary R. Johnson. A bioactive and highly flowable mineral root canal sealer, BioRoot® Flow is based on Septodont’s patented Active Biosilicate Technology (ABS), which is composed of calcium carbonate, zirconium oxide, and tricalcium silicate, among other components.

Building a Future-Proof Dental Practice: Which Tech Investments Actually Pay Off

Every dental conference has a show floor full of technology that promises to transform your practice. Scanners, printers, AI platforms, imaging systems, lasers, practice management software, patient communication tools each one pitched as the thing that separates a thriving modern practice from one that’s falling behind.

Clinical Case Study: Root canal re-treatment success with BioRoot Flow

CLINICAL CASE I By Dr. Lauren Kuhn Nuth. The success rate of non-surgical root canal treatment is high, however, inadequate obturation and inability to seal anatomical complexities can play a role in the long-term success of endodontic treatment. Traditional root canal sealers tend to shrink or wash-out—BioRoot™ Flow is a mineralbased, tricalcium silicate sealer with bioactive properties which slightly expands upon setting and has a high pH, therefore providing antimicrobial

properties.

The Menopause Symptom No One Talks About

An interview with Ms. Tatiana Brandt, MEd, RDH, Denmark. Menopause comes with a long list of symptoms most people can recite by heart – hot flashes, night sweats, mood swings. But there’s another change that often slips under the radar, even though it affects daily comfort, oral health, and overall wellbeing. Dry mouth, a surprisingly common yet rarely discussed symptom, can quietly reshape how women experience this stage of life.

Topical Fluoride Treatments – What do you prioritise?

Article by Stephen Langdon, Solventum Clinical Specialist. The first rosin based fluoride varnish was introduced way back in the 1960’s and apart from the more recent inclusion of various forms of calcium and phosphate in 2 or 3 commercially available varnish options and a change to unit dose packaging, there has been very little advancement in fluoride treatment technology for many years.

New to Henry Schein?

Existing Customers

Search Results for

Filter By

All Results

Article

Henry Schein: Delivering Solutions for a Healthier Tomorrow